SYRE
Price
$15.11
Change
+$0.45 (+3.07%)
Updated
May 2 closing price
Capitalization
910.76M
4 days until earnings call
TCRX
Price
$1.60
Change
+$0.05 (+3.23%)
Updated
May 2 closing price
Capitalization
90.55M
9 days until earnings call
Ad is loading...

SYRE vs TCRX

Header iconSYRE vs TCRX Comparison
Open Charts SYRE vs TCRXBanner chart's image
Spyre Therapeutics
Price$15.11
Change+$0.45 (+3.07%)
Volume$499.92K
Capitalization910.76M
TScan Therapeutics
Price$1.60
Change+$0.05 (+3.23%)
Volume$348.42K
Capitalization90.55M
SYRE vs TCRX Comparison Chart
Loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SYRE vs. TCRX commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a StrongBuy and TCRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (SYRE: $15.11 vs. TCRX: $1.60)
Brand notoriety: SYRE and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 68% vs. TCRX: 75%
Market capitalization -- SYRE: $910.76M vs. TCRX: $90.55M
SYRE [@Biotechnology] is valued at $910.76M. TCRX’s [@Biotechnology] market capitalization is $90.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 4 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than TCRX.

Price Growth

SYRE (@Biotechnology) experienced а +6.94% price change this week, while TCRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

SYRE is expected to report earnings on Jul 31, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($911M) has a higher market cap than TCRX($90.5M). SYRE YTD gains are higher at: -35.095 vs. TCRX (-47.368). TCRX has higher annual earnings (EBITDA): -119.74M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. TCRX (290M). SYRE has less debt than TCRX: SYRE (0) vs TCRX (97.4M). TCRX has higher revenues than SYRE: TCRX (2.82M) vs SYRE (0).
SYRETCRXSYRE / TCRX
Capitalization911M90.5M1,007%
EBITDA-208.57M-119.74M174%
Gain YTD-35.095-47.36874%
P/E Ratio1.72N/A-
Revenue02.82M-
Total Cash603M290M208%
Total Debt097.4M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETCRX
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSSAX27.540.56
+2.08%
Emerald Finance & Bking Innovt Fd A
ABCSX15.180.31
+2.08%
AB Discovery Value C
PJRCX7.850.13
+1.68%
PGIM Quant Solutions International Eq C
JMVZX31.430.49
+1.58%
JPMorgan Mid Cap Value R2
NLCCX29.870.40
+1.36%
Voya Large-Cap Growth C

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with APGE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+3.07%
APGE - SYRE
52%
Loosely correlated
+2.35%
CGON - SYRE
52%
Loosely correlated
+4.72%
PRME - SYRE
50%
Loosely correlated
-3.45%
ACLX - SYRE
50%
Loosely correlated
+0.03%
IMNM - SYRE
49%
Loosely correlated
-0.11%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with PRME. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+3.23%
PRME - TCRX
45%
Loosely correlated
-3.45%
FATE - TCRX
45%
Loosely correlated
+5.65%
IMNM - TCRX
44%
Loosely correlated
-0.11%
SYRE - TCRX
43%
Loosely correlated
+3.07%
IDYA - TCRX
42%
Loosely correlated
+2.25%
More